The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AKERO THERAPEUTICS INC | COM | 00973Y108 | 7,597 | 396,695 | SH | OTR | 396,695 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 20,582 | 475,000 | SH | OTR | 475,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 29,016 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 28,316 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 32,661 | 1,733,583 | SH | OTR | 1,733,583 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 111,555 | 900,000 | SH | OTR | 900,000 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 2,006 | 920,000 | SH | OTR | 920,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 8,950 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 43,566 | 5,300,000 | SH | OTR | 5,300,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 45,357 | 975,000 | SH | OTR | 975,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 13,150 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 41,588 | 1,875,000 | SH | OTR | 1,875,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 7,612 | 764,252 | SH | OTR | 764,252 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 91,084 | 6,567,000 | SH | OTR | 6,567,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 7,597 | 3,688,100 | SH | OTR | 3,688,100 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,430 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 3,934 | 290,577 | SH | OTR | 290,577 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 16,634 | 844,789 | SH | OTR | 844,789 | 0 | 0 | ||
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 5,319 | 575,000 | SH | OTR | 575,000 | 0 | 0 | ||
MATINAS BIOPHARMA HLDGS INC | COM | 576810105 | 8,727 | 10,188,312 | SH | OTR | 10,188,312 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 27,353 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 7,283 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 8,440 | 2,084,000 | SH | OTR | 2,084,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 29,925 | 1,102,194 | SH | OTR | 1,102,194 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 176,703 | 1,715,560 | SH | OTR | 1,715,560 | 0 | 0 | ||
NOVUS THERAPEUTICS INC | COM | 67011N105 | 328 | 324,383 | SH | OTR | 324,383 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 123,402 | 3,363,377 | SH | OTR | 3,363,377 | 0 | 0 | ||
PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 14,825 | 1,123,105 | SH | OTR | 1,123,105 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 45,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 21,991 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 19,971 | 3,473,272 | SH | OTR | 3,473,272 | 0 | 0 | ||
SPARK THERAPEUTICS INC | COM | 84652J103 | 61,428 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 48,094 | 615,400 | SH | OTR | 615,400 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 2,722 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 26,090 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 |